Suppr超能文献

完整切除肺炎性假瘤具有良好的长期预后。

Complete resection of pulmonary inflammatory pseudotumors has excellent long-term prognosis.

作者信息

Fabre Dominique, Fadel Elie, Singhal Sunil, de Montpreville Vincent, Mussot Sacha, Mercier Olaf, Chataigner Olivier, Dartevelle Philippe G

机构信息

Department of Thoracic and Vascular Surgery and Heart-Lung Transplantation, Hôpital Marie-Lannelongue, Le Plessis Robinson, Paris-Sud University, France.

出版信息

J Thorac Cardiovasc Surg. 2009 Feb;137(2):435-40. doi: 10.1016/j.jtcvs.2008.07.009. Epub 2008 Sep 19.

Abstract

OBJECTIVE

Pulmonary inflammatory pseudotumor is an uncommon disease, often with a benign presentation. However, invasion of adjacent thoracic organs, local recurrence, and distant metastases have been described, and the best management strategy remains unclear. We present a single large institutional experience in patients with pulmonary inflammatory pseudotumor and propose guidelines for treatment of this patient population.

METHODS

A retrospective study was performed to review all patients who underwent resection for pulmonary inflammatory pseudotumor between 1974 and 2007.

RESULTS

A total of 25 patients were treated with pulmonary inflammatory pseudotumor at the Marie Lannelongue Hospital. The mean age was 33 years. Two patients were referred after an incomplete resection. One patient presented with cerebral metastasis. We performed a complete resection in all patients: wedge resection (n = 7), lobectomy (n = 6), sleeve arterial lobectomy (n = 1), lobectomy with thoracic inlet exenteration (n = 2), bilobectomy (n = 2), pneumonectomy with brain metastasectomy (n = 1), sleeve pneumonectomy (n = 2), sleeve main bronchus or tracheal resection (n = 2), wedge with sleeve main pulmonary artery resections (n = 1), and sleeve pneumonectomy with esophageal, aortic arch, and right pulmonary artery resection (n = 1). No adjuvant therapy was given to any patients. Postoperative 30-day mortality and morbidity rates were 4% and 8%, respectively. With a mean follow-up of 80 months (range 4-369 months, 100% follow-up), actuarial 10-year survival was 89%. One patient died of an extensive sarcomatous recurrence 2 years after surgery.

CONCLUSION

Pulmonary inflammatory pseudotumor is a malignant disease affecting young patients with local invasion, distant metastasis, local recurrence, and sarcomatous degeneration. A complete resection should always be performed at initial presentation because of its high likelihood of cure with aggressive management.

摘要

目的

肺炎性假瘤是一种罕见疾病,通常表现为良性。然而,已有关于其侵犯相邻胸内器官、局部复发及远处转移的报道,最佳治疗策略仍不明确。我们介绍了一家大型机构对肺炎性假瘤患者的治疗经验,并提出了针对该患者群体的治疗指南。

方法

进行一项回顾性研究,以回顾1974年至2007年间所有因肺炎性假瘤接受手术切除的患者。

结果

玛丽·拉内隆格医院共有25例患者接受了肺炎性假瘤治疗。平均年龄为33岁。2例患者在不完全切除后转诊。1例患者出现脑转移。我们对所有患者均进行了完整切除:楔形切除术(n = 7)、肺叶切除术(n = 6)、袖状动脉肺叶切除术(n = 1)、经胸廓入口扩大切除术的肺叶切除术(n = 2)、双肺叶切除术(n = 2)、脑转移瘤切除术的全肺切除术(n = 1)、袖状全肺切除术(n = 2)、袖状主支气管或气管切除术(n = 2)、楔形联合袖状主肺动脉切除术(n = 1)以及食管、主动脉弓和右肺动脉切除术的袖状全肺切除术(n = 1)。所有患者均未接受辅助治疗。术后30天死亡率和发病率分别为4%和8%。平均随访80个月(范围4 - 369个月,随访率100%),10年精算生存率为89%。1例患者术后2年死于广泛的肉瘤样复发。

结论

肺炎性假瘤是一种影响年轻患者的恶性疾病,具有局部侵犯、远处转移、局部复发和肉瘤样变性。由于积极治疗有很高的治愈可能性,因此初次就诊时应始终进行完整切除。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验